HQISX Hartford Equity Income R4 Forecast, Technical & Fundamental Analysis

The most notable companies in this group are JPMorgan Chase & Co (NYSE:JPM), Unitedhealth Group (NYSE:UNH), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Philip Morris International (NYSE:PM), Cisco Systems (NASDAQ:CSCO), Pfizer (NYSE:PFE), ConocoPhillips (NYSE:COP), EOG Resources (NYSE:EOG), MetLife (NYSE:MET).

The investment seeks a high level of current income consistent with growth of capital. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its assets in equity securities. It invests primarily in equity securities of companies with market capitalizations above $2 billion. At the time of investment, every equity security in which the fund invests must pay a dividend or be expected to pay a dividend within the next 12 months. It may invest up to 20% of its net assets in the securities of foreign issuers and non-dollar securities.

The average market capitalization across the Hartford Equity Income R4 MF is 266.18B. The market cap for tickers in the group ranges from 53.28B to 573.02B. JPM holds the highest valuation in this group at 573.02B. The lowest valued company is MET at 53.28B.

The average weekly volume growth across all stocks in the Hartford Equity Income R4 MF was 36%. For the same stocks of the MF, the average monthly volume growth was -30% and the average quarterly volume growth was 41%